Navigation Links
NeuroDerm Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinson's Disease
Date:3/4/2013

NESS ZIONA, Israel, March 4, 2013 /PRNewswire/ --

NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously sub-cutaneously through a patch pump. It is designed to provide steady levodopa blood levels for the reduction of motor complications in Parkinson's disease. Results of this study support the continued development of ND0612 for the treatment of Parkinson's disease.

In this double-blind, placebo controlled, dose-escalation trial in young, healthy volunteers, ND0612 was shown to be safe and tolerable in all of the tested doses. Furthermore, clinically meaningful levodopa concentrations were reached and, for the first time in man, steady state levodopa concentrations were maintained in a practical manner both day and night. The full results of this study will be presented at a future scientific meeting.

"ND0612's success in its first phase I trial means that clinically significant steady state levodopa concentrations can, for the first time, be maintained, both day and night, through a conveniently administered drug. With ND0612, steady state levodopa levels, the elusive holy grail of Parkinson's levodopa therapy, should be available to all PD patients. Moreover, as ND0612 bypasses the gastrointestinal tract, steady state levodopa levels should be little influenced by intestinal absorption or oral ingestion of food or drugs. We believe that ND0612 could become a breakthrough treatment option that may establish a new, significantly higher standard of care for Parkinson's patients."

About Parkinson's Disease

Parkinson's disease affects approximately 6 million patients in the world. It is caused by decreasing dopamine signaling in the brain as dopam
'/>"/>

SOURCE NeuroDerm Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
2. Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Affymax, Inc.
3. PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results
4. Hospira Announces Executive Changes
5. Citiustech Announces Launch of Bi-Clinical Cloud and App-Based Architecture
6. DMH International Announces FDA Approval of TouchPACS
7. ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
8. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
9. Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference
10. Rigel Announces Participation at Two Investor Conferences
11. Pharmacy Technician Certification Board Announces Certification Program Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... CHAGRIN FALLS, Ohio , July 30, 2015 /PRNewswire/ ... in his OMTEC® 2015 keynote address last month that ... business models in order to gain the efficiencies—and develop ... future. Dr. Barsoum,s comments were preceded by ... Tornier, avid entrepreneur and OMTEC moderator, who stressed that ...
(Date:7/30/2015)... , July 30, 2015  Growth of the U.S. ... they bring former prescription users to the OTC market. ... forecasts robust Rx-to-OTC switch activity over the next ... along with many new brands entering the market into ... the next five years (even those with low to ...
(Date:7/30/2015)... 30, 2015 P&S ... with market overview, trends, DRO analysis, market ... recent developments, competitive scenario and top competitor ... Biosensors Market Development and Demand Forecast to ... ) Explore more about global ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5
(Date:7/31/2015)... Waycross, Georgia (PRWEB) , ... July 31, 2015 , ... Easter Seals Southern Georgia’s Heels ... Park near Waycross, Georgia. Start time will be 7:30 AM. The duathlon is a 2 ... quarter mile swim in Laura Walker Lake, a 13 mile bike, and a 3 mile ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... applies when purchasing disability insurance, where price is an important factor to clients ... a leading insurance carrier, offers the Preferred Producer Multi-Life Discount program, where advisers ...
(Date:7/30/2015)... ... , ... When responsible for the care of an aging loved one, summer ... mind: What happens if mom falls? Who will remind Dad to take his medications? ... But not taking time away from caregiving responsibilities can lead to bigger problems – ...
(Date:7/30/2015)... Turks & Caicos Islands, BWI (PRWEB) , ... July 31, 2015 , ... The Venetian ... offer for fall, 2015. Guests who stay at the Venetian will save 40% on ... , The fall months are always quiet in the Turks & Caicos, providing a chance ...
(Date:7/30/2015)... ... 2015 , ... World Patent Marketing, a vertically integrated manufacturer ... can help people during emergencies. , "The worldwide mobile health market revenue will ... World Patent Marketing. "Currently, there are about 97,000 mobile health apps available in ...
Breaking Medicine News(10 mins):Health News:Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5
... News) -- Men develop type 2 diabetes at a lower ... why men have higher rates of diabetes in many parts ... 51,920 men and 43,137 women in Scotland with diabetes and ... men and 33.69 in women. This difference was most noticeable ...
... (HealthDay News) -- Women with polycystic ovary syndrome (PCOS), an ... to have parents with some form of heart disease, according ... between PCOS and other family medical conditions, we might be ... an earlier stage," the study,s lead author, Michael Davies, an ...
... , FRIDAY, Oct. 7 (HealthDay News) -- Boys with autism ... developing infants seen in their head size, height and weight, ... offer new clues about the underlying mechanisms of autism. A ... larger brain. Boys with brain and body "overgrowth" ...
... that high-calorie energy drink or soda might present more ... double-blind, placebo-controlled study that examined responses to stimulants, an ... or she will respond to other stimulant drugs, possibly ... serious drugs of abuse, such as amphetamine and cocaine. ...
... through organ transplantation has been revolutionized by the development of ... organ. But those antirejection drugs have their own side ... by scientists at Oregon Health & Science University has discovered ... effects. And the discovery means those side effects likely can ...
... , FRIDAY, Oct. 7 (HealthDay News) -- Nearly your ... play games, according to a new study. The finding ... in an attempt to win games, such as rock-paper-scissors, makes ... "Our brain functions to maximize the chance of survival ...
Cached Medicine News:Health News:Boys With Autism May Grow Faster as Babies 2Health News:Boys With Autism May Grow Faster as Babies 3Health News:Jonesing for java: Could caffeine use predict risk for cocaine abuse? 2Health News:Study uncovers why anti-rejection drugs for transplant patients cause hypertension 2
... new SONOLINE G40 ultrasound system brings,the ... an entirely new level of diagnostic ... ultra-portable,system that meets your clinical needs. ... color,Doppler and pulsed-wave Doppler capabilities,the G40 ...
... unique Acid Fast Control Slides ... with appropriate background material. Slides ... positive and negative smear. Can ... No. 353), Ziehl-Neelsen or SDLs ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Each slide contains a gram positive control of Staphylococcus aureus ATCC ® 25923 and a gram negative control of Escherichia coli ATCC ® 25922....
Medicine Products: